NANOG and renal cell carcinoma: Data revealed that abnormal elevated expression levels of key stemness factors, such as OCT4 and NANOG, in several types of CSCs, the role of these CSC markers in generation and maintenance of renal CSC, and the importance and therapeutic potential of targeting these stemness regulators in RCC have attracted the attention of the researchers.